US FDA back in business after shutdown, but regulatory work has 'piled up'

US FDA back in business after shutdown, but regulatory work has 'piled up'-spglobal: After 35 days of having about half of its employees either fully or partially furloughed, the U.S. Food and Drug Administration is back in business, though its leaders acknowledged the shutdown has put the agency behind in its regulatory work.